# SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19

> **NCT04979871** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 50 (actual)

## Conditions studied

- Vaccine Reaction

## Interventions

- **PROCEDURE:** Venous bleeding

## Key facts

- **NCT ID:** NCT04979871
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-22
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979871, "SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04979871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*